Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 457
Ph III recruiting: 55
Growth YoY: −4.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 151–200 of 330 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01068249	Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer	active not recruiting	Phase 2	42	M.D. Anderson Cancer CenterOTHER	1	Apr 30, 2026	clinicaltrials
NCT03682289	Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors	active not recruiting	Phase 2	83	Rahul AggarwalOTHER	1	Apr 23, 2026	clinicaltrials